EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Innovative Strategies for the Targeted Degradation of Viral Proteins: Paving the Way for Next-Generation Therapeutics

Alexander S Sobolev, Georgii P Georgiev

Pharmaceutics · 03.11.2025 · 17 (11) · 1420

DOI: 10.3390/pharmaceutics17111420 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 03.11.2025. Verfasst von Alexander S Sobolev und 1 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Biology, Lomonosov Moscow State University, 1-12 Leninskiye Gory St., 119234 Moscow, Russia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: This review discusses the development and application of targeted protein degradation strategies, particularly focusing on the ubiquitin–proteasome pathway and PROteolysis-TArgeting Chimeras (PROTAC) technology, for antiviral therapies. Methods/Results: The synthesis of specific PROTACs exemplifies the potential of this approach to inhibit viral replication. The discussion also covers ongoing efforts to develop broad-spectrum antivirals and explores the limitations of small-molecule ligands, proposing antibody mimetics as a versatile alternative. The review details innovative strategies involving engineered antibody mimetics, termed ‘diving antibodies’ (DAbs), capable of intracellular delivery and targeting viral proteins within cells. These molecules are engineered using modular nanotransporters to facilitate intracellular delivery. The integration of E3 ligase-binding sites into DAbs enhances their capacity to induce targeted protein degradation, with experimental evidence supporting their efficacy. Conclusions: Overall, the review underscores the potential of combining targeted degradation technologies with innovative delivery systems to create effective antiviral therapies, especially for viruses with limited treatment options.

Schlagwörter

Stichwörter der Autor:innen

PROTACsdiving antibodiesintracellular deliverymodular nanotransporterstargeted protein degradationviral proteins

Autor:innen und Institutionen

  • Faculty of Biology, Lomonosov Moscow State University, 1-12 Leninskiye Gory St., 119234 Moscow, Russia.
  • Institute of Gene Biology, Russian Academy of Sciences, 34/5 Vavilov St., 119334 Moscow, Russia.

Förderung

  • Russian Science Foundation

Zitieren

APA

Sobolev, A. S., & Georgiev, G. P. (2025). Innovative Strategies for the Targeted Degradation of Viral Proteins: Paving the Way for Next-Generation Therapeutics. Pharmaceutics, 17(11), 1420. https://doi.org/10.3390/pharmaceutics17111420

Vancouver

Sobolev AS, Georgiev GP. Innovative Strategies for the Targeted Degradation of Viral Proteins: Paving the Way for Next-Generation Therapeutics. Pharmaceutics. 2025;17(11):1420. doi:10.3390/pharmaceutics17111420

BibTeX
@article{Sobolev2025,
  author = {Sobolev, Alexander S and Georgiev, Georgii P},
  title = {Innovative Strategies for the Targeted Degradation of Viral Proteins: Paving the Way for Next-Generation Therapeutics},
  journal = {Pharmaceutics},
  year = {2025},
  volume = {17},
  number = {11},
  pages = {1420},
  doi = {10.3390/pharmaceutics17111420}
}
Kostenlos starten →